Jackson Square Partners Has Upped Abiomed Com (ABMD) Holding By $4.47 Million; Evogene Limited Ord (EVGN) SI Decreased By 37.93%

July 24, 2017 - By Richard Conner

Evogene Limited Ord (NASDAQ:EVGN) had a decrease of 37.93% in short interest. EVGN’s SI was 3,600 shares in July as released by FINRA. Its down 37.93% from 5,800 shares previously. With 2,400 avg volume, 2 days are for Evogene Limited Ord (NASDAQ:EVGN)’s short sellers to cover EVGN’s short positions. The SI to Evogene Limited Ord’s float is 0.02%. About 16,705 shares traded or 23.93% up from the average. Evogene Ltd (NASDAQ:EVGN) has declined 23.47% since July 24, 2016 and is downtrending. It has underperformed by 40.17% the S&P500.

Jackson Square Partners Llc increased Abiomed Inc Com (ABMD) stake by 5.97% reported in 2016Q4 SEC filing. Jackson Square Partners Llc acquired 39,951 shares as Abiomed Inc Com (ABMD)’s stock rose 15.32%. The Jackson Square Partners Llc holds 708,724 shares with $79.86 million value, up from 668,773 last quarter. Abiomed Inc Com now has $6.41B valuation. The stock rose 1.01% or $1.46 reaching $145.56 per share. About 80,289 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 40.97% since July 24, 2016 and is uptrending. It has outperformed by 24.27% the S&P500.

Jackson Square Partners Llc decreased Walgreens Boots Alliance Inc Com stake by 459,593 shares to 3.63 million valued at $300.21M in 2016Q4. It also reduced Tencent Hldgs Limited Common Stock (TCTZF) stake by 291,948 shares and now owns 3.66M shares. Alphabet Inc Cap Stk Cl C Cap Stk Cl C was reduced too.

Among 10 analysts covering Abiomed (NASDAQ:ABMD), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Abiomed had 17 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, June 8 by William Blair. As per Tuesday, August 18, the company rating was initiated by Sterne Agee CRT. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Tuesday, August 4 by Benchmark. The stock has “Hold” rating by Piper Jaffray on Wednesday, August 5. The firm has “Buy” rating given on Tuesday, June 6 by Jefferies. The rating was maintained by Jefferies with “Buy” on Tuesday, August 9. Raymond James upgraded the stock to “Outperform” rating in Friday, October 30 report. As per Tuesday, August 4, the company rating was maintained by BTIG Research. Leerink Swann maintained the stock with “Outperform” rating in Wednesday, May 4 report. PiperJaffray upgraded ABIOMED, Inc. (NASDAQ:ABMD) on Thursday, April 6 to “Overweight” rating.

Investors sentiment increased to 1.01 in 2016 Q4. Its up 0.03, from 0.98 in 2016Q3. It is positive, as 36 investors sold ABMD shares while 102 reduced holdings. 40 funds opened positions while 100 raised stakes. 37.23 million shares or 0.30% less from 37.34 million shares in 2016Q3 were reported. Hl Fincl Ltd Company owns 28,512 shares or 0.07% of their US portfolio. One Trading Limited Partnership holds 0% or 264 shares in its portfolio. Marshall Wace Llp has 0.04% invested in ABIOMED, Inc. (NASDAQ:ABMD). Wilbanks Smith And Thomas Asset Mgmt Limited Liability stated it has 2,296 shares or 0.02% of all its holdings. Sunbelt Securities stated it has 504 shares or 0% of all its holdings. Quantbot Techs LP reported 11,720 shares or 0.15% of all its holdings. Utah Retirement stated it has 7,300 shares. Tci Wealth Advisors Inc reported 0% in ABIOMED, Inc. (NASDAQ:ABMD). Swiss Bank & Trust owns 67,300 shares or 0.01% of their US portfolio. Rockefeller Fincl Inc holds 0.53% or 231,622 shares in its portfolio. Next Century Growth Invsts Limited Liability Corp owns 2.74% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 397,050 shares. Navellier And invested 0.18% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Castleark Mgmt Limited Liability Company owns 407,439 shares or 1.46% of their US portfolio. Axa stated it has 0.02% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Moreover, Parametric Portfolio Assocs Limited Liability has 0.01% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 41,212 shares.

Since February 6, 2017, it had 0 insider buys, and 6 insider sales for $10.61 million activity. The insider Weber David M sold $2.78 million. $79,701 worth of ABIOMED, Inc. (NASDAQ:ABMD) was sold by Howley Michael G. $1.77M worth of ABIOMED, Inc. (NASDAQ:ABMD) shares were sold by PUHY DOROTHY E. On Friday, March 17 the insider Greenfield Andrew J sold $1.24 million.